Clinical Trials on Overactive Detrusor in New Zealand
Total 216 results
-
Astellas Pharma IncCompletedOveractive Bladder | Detrusor OveractivityBelgium, Norway, Spain, Sweden, Italy, Czech Republic, Hungary, France, Canada, Germany, Austria, United Kingdom, Bulgaria, Russian Federation, United States, Poland, Slovakia, Turkey, Israel, Romania
-
Northwell HealthMedtronics, Inc.CompletedDetrusor OveractivityUnited States
-
Astellas Pharma Europe B.V.CompletedPediatric | Neurogenic Detrusor OveractivityUnited States, Belgium, Korea, Republic of, Philippines, Poland, United Kingdom
-
Astellas Pharma Europe B.V.CompletedNeurogenic Detrusor OveractivityBelgium, Croatia, Turkey, Australia, Denmark, Israel, Jordan, Korea, Republic of, Latvia, Lithuania, Malaysia, Mexico, Norway, Philippines, Poland, Romania, Serbia, Slovakia, Taiwan
-
University of Auckland, New ZealandAuckland District Health BoardUnknownPeritoneal Dessication Damage and Inflammation | Peri-operative HypothermiaNew Zealand
-
Astellas Pharma Europe B.V.CompletedNeurogenic Detrusor OveractivityUnited States, Belgium, Brazil, Denmark, Hungary, Korea, Republic of, Mexico, Philippines, Poland, Turkey
-
University of OtagoAustralian and New Zealand College of AnaesthetistsCompletedAdult Patients Scheduled for 3rd Molar Teeth ExtractionsNew Zealand
-
AbbVieCompletedOveractive Detrusor | Neurogenic BladderUnited States
-
Auckland City HospitalHealth Research Council, New Zealand; Australian and New Zealand College of...CompletedSurgery--Complications | Long Term Adverse Effects | Post-Operative Confusion | Cognitive Dysfunction, PostoperativeNew Zealand
-
Warner ChilcottTerminatedNeurogenic Detrusor OveractivityUnited States, Colombia
-
AllerganCompletedOveractive BladderUnited Kingdom, Belgium, New Zealand, France, Russian Federation, Czech Republic, United States, Germany, Austria, Poland, Slovakia, Ukraine, Canada, Australia
-
Valencia Technologies CorporationCompletedOveractive Bladder | Urge Incontinence | Urinary Urge Incontinence | Incontinence, UrinaryUnited States, New Zealand
-
Urovant Sciences GmbHRecruitingNeurogenic Detrusor OveractivityUnited States
-
Taipei Medical University Shuang Ho HospitalCompletedLower Urinary Tract Symptoms | Overactive Bladder SyndromeTaiwan
-
BayerCompletedOveractive BladderAustria, Singapore, New Zealand, Australia, Portugal, Czechia, Poland, Germany, Sweden
-
PfizerCompletedTreatment of Overactive BladderUnited States
-
PfizerCompletedTreatment of Overactive BladderUnited States
-
NovartisCompletedOveractive Bladder SyndromeUnited States
-
En Chu Kong HospitalCompleted
-
NovartisCompletedOveractive Bladder SyndromeUnited States
-
Far Eastern Memorial HospitalRecruitingOveractive Bladder SyndromeTaiwan
-
Far Eastern Memorial HospitalRecruitingOveractive Bladder SyndromeTaiwan
-
Far Eastern Memorial HospitalWithdrawnOveractive Bladder SyndromeTaiwan
-
Medstar Health Research InstituteColumbia University; University of Michigan; University of New Mexico; Methodist...Terminated
-
Far Eastern Memorial HospitalCompletedOveractive Bladder SyndromeTaiwan
-
PfizerCompletedOveractive Bladder (OAB) With Symptoms of Frequency, Urgency, and UrgencyUnited States
-
InnoCon MedicalOdense University Hospital; Aarhus University Hospital; Herlev HospitalCompletedUrinary Incontinence | Fecal Incontinence | Urge Incontinence | Urinary Incontinence, Urge | Nocturia | Urinary Frequency More Than Once at Night | Incontinence, Nighttime Urinary | Bowel Disorders FunctionalDenmark
-
Astellas Pharma Global Development, Inc.CompletedOveractive Bladder (OAB)United States, Canada
-
Weill Medical College of Cornell UniversityNaturex-DbsCompletedOveractive BladderUnited States
-
Weill Medical College of Cornell UniversityLaborie Medical Technologies Inc.; Urodynamix TechnologiesCompleted
-
Far Eastern Memorial HospitalNational Science Council, TaiwanCompletedOveractive Bladder Syndrome | Lower Urinary Tract DysfunctionTaiwan
-
Watson PharmaceuticalsCompletedDetrusor HyperreflexiaUnited States
-
Far Eastern Memorial HospitalCompletedOveractive BladderTaiwan
-
Astellas Pharma Global Development, Inc.CompletedOveractive Bladder (OAB)United States, Canada
-
GlaxoSmithKlineCompletedOveractive BladderUnited States
-
Weill Medical College of Cornell UniversityCompletedOveractive BladderUnited States
-
Far Eastern Memorial HospitalRecruitingOveractive Bladder SyndromeTaiwan
-
Far Eastern Memorial HospitalRecruitingFemale Patients With Overactive Bladder SyndromeTaiwan
-
GlaxoSmithKlineCompletedOveractive BladderAustralia
-
Stony Brook UniversityLaborie Medical Technologies Inc.TerminatedOveractive Bladder SyndromeUnited States
-
PfizerCompletedOveractive Bladder With Symptoms of Frequency, Urgency, and Urge Urinary IncontinenceUnited States
-
Watson PharmaceuticalsCompletedDetrusor HyperreflexiaUnited States
-
Urovant Sciences GmbHIon Channel InnovationsCompletedOveractive BladderUnited States
-
AllerganCompletedOveractive BladderPoland, United Kingdom, Portugal, South Africa, Ukraine, Australia, Netherlands, Canada, Singapore, Russian Federation, Germany, Brazil, Austria, Slovakia, Czechia, United States, Taiwan, Italy, France, Belgium, Spain, New Zealand
-
Icahn School of Medicine at Mount SinaiCompletedOveractive Bladder | Pelvic Organ ProlapseUnited States
-
University of RochesterCompletedOveractive BladderUnited States
-
Taris Biomedical LLCCompletedIdiopathic Overactive Bladder With Urinary IncontinenceUnited States
-
NovartisProcter and GambleCompletedOveractive Bladder (OAB)United States
-
MedtronicNeuroCompletedOveractive BladderUnited States
-
Memorial Sloan Kettering Cancer CenterCompletedOperative TimeUnited States